Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study.
Mantini G, Valentini V, Meduri B, Margaritora S, Balducci M, Micciché F, Nardone L, De Rose F, Cesario A, Larici AR, Maggi F, Calcagni ML, Granone P. Mantini G, et al. Among authors: meduri b. Radiother Oncol. 2012 Nov;105(2):161-6. doi: 10.1016/j.radonc.2012.09.006. Epub 2012 Oct 12. Radiother Oncol. 2012. PMID: 23068709 Clinical Trial.
A national multicenter study on 1072 DCIS patients treated with breast-conserving surgery and whole breast radiotherapy (COBCG-01 study).
Meattini I, Pasinetti N, Meduri B, De Rose F, De Santis MC, Franco P, Lancellotta V, Rossi F, Saieva C, Desideri I, Delli Paoli C, D'Angelo E, Triggiani L, Bastiani P, Alongi F, Lozza L, Aristei C, Ricardi U, Scorsetti M, Livi L; Clinical Oncology Breast Cancer Group (COBCG) Investigators. Meattini I, et al. Among authors: meduri b. Radiother Oncol. 2019 Feb;131:208-214. doi: 10.1016/j.radonc.2018.07.015. Epub 2018 Jul 31. Radiother Oncol. 2019. PMID: 30075864 Free article.
Local Treatment of the Axilla in Early Breast Cancer: So Many Questions, Still Few Answers.
Meattini I, De Santis MC, De Rose F, Desideri I, Franco P, Kaidar-Person O, Meduri B, Pasinetti N, Lancellotta V; Clinical Oncology Breast Cancer Group (COBCG) Investigators. Meattini I, et al. Among authors: meduri b. Clin Oncol (R Coll Radiol). 2020 Jan;32(1):e37-e38. doi: 10.1016/j.clon.2019.08.001. Epub 2019 Aug 14. Clin Oncol (R Coll Radiol). 2020. PMID: 31421912 No abstract available.
Omission of postoperative radiation after breast conserving surgery: A progressive paradigm shift towards precision medicine.
Franco P, De Rose F, De Santis MC, Pasinetti N, Lancellotta V, Meduri B, Meattini I; Clinical Oncology Breast Cancer Group (COBCG) Investigators. Franco P, et al. Among authors: meduri b. Clin Transl Radiat Oncol. 2020 Feb 8;21:112-119. doi: 10.1016/j.ctro.2020.02.003. eCollection 2020 Mar. Clin Transl Radiat Oncol. 2020. PMID: 32090175 Free PMC article. Review.
Comparing hypofractionated and conventionally fractionated whole breast irradiation for patients with ductal carcinoma in situ after breast conservation: a propensity score-matched analysis from a national multicenter cohort (COBCG-02 study).
De Rose F, De Santis MC, Meduri B, Franzese C, Franceschini D, Franco P, Pasinetti N, Lancellotta V, Giacobazzi P, La Rocca E, D'Angelo E, Lozza L, Livi L, Meattini I, Scorsetti M. De Rose F, et al. Among authors: meduri b. J Cancer Res Clin Oncol. 2021 Jul;147(7):2069-2077. doi: 10.1007/s00432-020-03483-5. Epub 2021 Jan 2. J Cancer Res Clin Oncol. 2021. PMID: 33387035
Lymph nodal radiotherapy in breast cancer: what are the unresolved issues?
Fozza A, Giaj-Levra N, De Rose F, Ippolito E, Silipigni S, Meduri B, Fiorentino A, Gregucci F, Marino L, Di Grazia A, Cucciarelli F, Borghesi S, De Santis MC, Ciabattoni A. Fozza A, et al. Among authors: meduri b. Expert Rev Anticancer Ther. 2021 Aug;21(8):827-840. doi: 10.1080/14737140.2021.1917390. Epub 2021 Apr 25. Expert Rev Anticancer Ther. 2021. PMID: 33852379 Review.
Breast reconstruction and radiation therapy: An Italian expert Delphi consensus statements and critical review.
Meattini I, Becherini C, Bernini M, Bonzano E, Criscitiello C, De Rose F, De Santis MC, Fontana A, Franco P, Gentilini OD, Livi L, Meduri B, Parisi S, Pasinetti N, Prisco A, Rocco N. Meattini I, et al. Among authors: meduri b. Cancer Treat Rev. 2021 Sep;99:102236. doi: 10.1016/j.ctrv.2021.102236. Epub 2021 May 27. Cancer Treat Rev. 2021. PMID: 34126314 Review.
Ways to improve breast cancer patients' management and clinical outcome: The 2020 Assisi Think Tank Meeting.
Aristei C, Bölükbaşı Y, Kaidar-Person O, Pfeffer R, Arenas M, Boersma LJ, Ciabattoni A, Coles CE, Franco P, Krengli M, Leonardi MC, Marazzi F, Masiello V, Meattini I, Montero A, Offersen B, Trigo ML, Bourgier C, Genovesi D, Kouloulias V, Morganti AG, Meduri B, Pasinetti N, Pedretti S, Perrucci E, Rivera S, Tombolini V, Vidali C, Valentini V, Poortmans P. Aristei C, et al. Among authors: meduri b. Crit Rev Oncol Hematol. 2022 Sep;177:103774. doi: 10.1016/j.critrevonc.2022.103774. Epub 2022 Jul 30. Crit Rev Oncol Hematol. 2022. PMID: 35917884 Review.
Rethinking breast cancer follow-up based on individual risk and recurrence management.
De Rose F, Meduri B, De Santis MC, Ferro A, Marino L, Colciago RR, Gregucci F, Vanoni V, Apolone G, Di Cosimo S, Delaloge S, Cortes J, Curigliano G. De Rose F, et al. Among authors: meduri b. Cancer Treat Rev. 2022 Sep;109:102434. doi: 10.1016/j.ctrv.2022.102434. Epub 2022 Jul 1. Cancer Treat Rev. 2022. PMID: 35933845 Free article. Review.
133 results